SecBot SecBot
DEFA14A ·Filed Jun 26, 2026

PDSB

PDS Biotechnology Corp
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago SEC0001140361-26-026570
Proxy solicitation materials
Actionable Insight • Neutral

This DEFA14A likely accompanies a definitive proxy statement (DEF14A) or preliminary materials related to an activist/dissident proxy contest. The cross-filing amplifiers strongly suggest an ongoing campaign with potential board changes or shareholder proposals. Traders should locate the related DEF14A or preliminary proxy for specific vote items and activist demands.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$0.8991
T+0 close · Jun 26, 2026 · via day close
Latest settled
+1.21%
T+60 · $0.9100
Vs SPY
−3.17%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 29 $0.8991entry
  2. T+1 · 5mo ago −2.00%α −2.78% · $0.8811
  3. T+5 · 4mo ago −5.89%α −7.28% · $0.8461
  4. T+20 · 4mo ago −24.21%α −23.93% · $0.6814
  5. T+60 · 8w ago +1.21%α −3.17% · $0.9100
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

PDS Biotechnology Corp filed a DEFA14A, which is additional definitive proxy soliciting material. The document body is almost entirely comprised of encoded/compressed graphical data and contains no readable text describing specific proposals, shareholder votes, or activist demands. With no substantive content available, the filing appears to be a routine cover-page-only submission of graphic exhibits related to a proxy solicitation.

Key Facts

  • Filed as DEFA14A (additional definitive proxy soliciting materials) on 2026-06-26
  • Filer is PDS Biotechnology Corp, a pharmaceutical preparations company
  • Document text contains only EDGAR headers, a Schedule 14A cover page, and two large binary graphic files (JPG images)
  • No textual details on meeting agenda, proposals, or activist demands were found in the filing
  • Evidence of an ongoing dissident proxy campaign indicated by cross-filing actuarial verdicts, which universally amplified the combination of 'dissident-proxy-activist-context' with preliminary, executive change, and DEF14A contexts

Financial Impact

No financial figures disclosed in the filing

Risk Factors

  • No substantive content in this filing limits actionable analysis
  • Activists/dissidents may be seeking board seats or strategic changes that could affect company direction
  • Proxy fights in small-cap biotechs (market cap ~$49M) can lead to significant stock volatility

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001140361-26-026570
Document: 0001140361-26-026570-index-headers.html0001140361-26-026570
Document: 0001140361-26-026570-index.html0001140361-26-026570
Document: 0001140361-26-026570.txt0001140361-26-026570

Track record

28 reports on PDSB

Performance horizon

7 of 14 bullish or bearish reports moved the stock their way by T+20. Best: +71.95% at T+20 after the Jul 22, 2026 report. 11 of 14 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $0.8726 Now $0.9240 +5.89% settles Dec 14
  2. Nov 12, 20264d ago SC 13D/A Neutral 4/10 Entry $0.9800 Now $0.9240 −5.71% settles Dec 11
  3. Nov 10, 20266d ago 8-K Neutral 4/10 Entry $1.03 Now $0.9240 −10.29% settles Dec 9
  4. Oct 20, 202627d ago 3 Neutral 2/10 Entry $1.24 Now $0.9240 −25.48% settles Nov 18
  5. Oct 20, 202627d ago 8-K Neutral 4/10 Entry $1.24 Now $0.9240 −25.48% settles Nov 18
  6. Oct 20, 202627d ago 8-K Neutral 3/10 Entry $0.9605 Now $0.9240 −3.80% settles Nov 17
  7. Oct 14, 20264w ago S-3 Bearish 7/10 Entry $1.30 to $0.9800 Now $0.9240 +28.92% ▲ +24.62% +22.71% vs SPY
  8. Oct 6, 20265w ago 8-K Neutral 3/10 Entry $1.05 to $1.41 Now $0.9240 −11.58% ▲ +34.93% +38.10% vs SPY
  9. Sep 22, 20267w ago 8-K Bullish 6/10 Entry $0.9100 to $0.9605 Now $0.9240 +1.54% ▲ +5.55% +6.11% vs SPY
  10. Sep 22, 20267w ago Press Release Bullish 7/10 Entry $0.9100 to $0.9605 Now $0.9240 +1.54% ▲ +5.55% +6.11% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026